» Authors » Michael R Johnston

Michael R Johnston

Explore the profile of Michael R Johnston including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 39
Citations 1473
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Brenner D, Hung R, Tsao M, Shepherd F, Johnston M, Narod S, et al.
BMC Cancer . 2010 Jun; 10:285. PMID: 20546590
Background: We conducted a case-control study in the greater Toronto area to evaluate potential lung cancer risk factors including environmental tobacco smoke (ETS) exposure, family history of cancer, indoor air...
12.
Dokouhaki P, Han M, Joe B, Li M, Johnston M, Tsao M, et al.
Cancer Lett . 2010 Jun; 297(1):126-36. PMID: 20537791
gammadelta T cells can be an option for adoptive immunotherapy of cancer. The major obstacle to clinical application of gammadelta T cells is their low number and lack of a...
13.
Cheung W, Hwang D, Chung T, Johnston M, Leighl N
Clin Lung Cancer . 2009 May; 10(3):187-92. PMID: 19443339
Background: Bronchioloalveolar carcinoma (BAC) commonly presents as multifocal disease. Management of multifocal BAC remains controversial and may include surgical resection, systemic therapy, surveillance, or a combination of these strategies. Knowledge...
14.
S Coonar A, Hughes J, Walker S, dePerrot M, Waddell T, Pierre A, et al.
Ann Thorac Surg . 2009 Apr; 87(5):1577-81. PMID: 19379910
Purpose: The purpose of this study was to implement real-time transthoracic ultrasound in a thoracic surgery and lung transplant practice. Description: Ultrasound units that are light, small, robust, and portable...
15.
Roberts H, Patsios D, Paul N, dePerrot M, Teel W, Bayanati H, et al.
J Thorac Oncol . 2009 Apr; 4(5):620-8. PMID: 19357540
Purpose: We established a screening program for prior asbestos workers using low-dose computed tomography (LDCT). Methods: Between March 2005 and October 2007 we performed LDCT (50-60 mA, 120 kV, 1.25...
16.
de Perrot M, Feld R, Cho B, Bezjak A, Anraku M, Burkes R, et al.
J Clin Oncol . 2009 Feb; 27(9):1413-8. PMID: 19224855
Purpose: Malignant pleural mesothelioma (MPM) remains associated with poor outcome. We examined the results of trimodality therapy with cisplatin-based chemotherapy followed by extrapleural pneumonectomy (EPP) and adjuvant high-dose (50 to...
17.
Anraku M, Waddell T, de Perrot M, Lewis S, Pierre A, Darling G, et al.
J Thorac Cardiovasc Surg . 2009 Feb; 137(2):441-447.e1. PMID: 19185167
Objective: We evaluated the outcome, long-term results, and factors affecting outcome of induction chemoradiotherapy followed by surgical resection for T4 non-small cell lung cancer invading the spine. Methods: Retrospective analysis...
18.
Liu J, Meisner D, Kwong E, Wu X, Johnston M
Cancer Res . 2009 Jan; 69(3):1174-81. PMID: 19176391
As a means of treating lymphatic metastasis from lung cancer, the pharmacokinetics and therapeutic effects of an intrapleural (ipl) implantable drug delivery system consisting of a gelatin sponge impregnated with...
19.
Anraku M, Cunningham K, Yun Z, Tsao M, Zhang L, Keshavjee S, et al.
J Thorac Cardiovasc Surg . 2008 Apr; 135(4):823-9. PMID: 18374762
Objective: The aim of the study was to determine the impact of tumor-infiltrating lymphocytes on survival in patients with malignant pleural mesothelioma treated with induction chemotherapy followed by extrapleural pneumonectomy....
20.
de Perrot M, McRae K, Anraku M, Karkouti K, Waddell T, Pierre A, et al.
Ann Thorac Surg . 2008 Mar; 85(4):1206-10. PMID: 18355497
Background: Factors associated with increased risk of major complications after extrapleural pneumonectomy (EPP) for malignant pleural mesothelioma are not well characterized; in particular, the risks of induction chemotherapy and red...